Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:
A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Macquarie is bullish on a supermarket giant, citing successful market share expansion and strong sales growth, leading to an outperform rating and increased price target.
  • A biotech leader is seen as undervalued by Morgans, which maintains a buy rating despite a recent guidance downgrade, highlighting a buying opportunity due to low earnings multiples.
  • Macquarie's positive view on a buy now pay later provider is driven by its rapid growth and potential in the US market, resulting in a new coverage with a favorable price target.

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

Coles Group Ltd (ASX: COL)

According to a note out of the Macquarie equities desk, its analysts have retained their outperform rating on this supermarket giant's shares with an improved price target of $26.10. The broker was pleased with Coles' first quarter update and notes that its sales growth outperformed its main rival. This suggests that its market share gains have continued. And with Coles appearing to be retaining its new shoppers, Macquarie believe it is well-placed to deliver strong earnings growth in the next three years. As a result, it thinks its shares are good value at current levels. The Coles share price ended the week at $22.05.

CSL Ltd (ASX: CSL)

A note out of Morgans reveals that its analysts have retained their buy rating on this biotech giant's shares with a reduced price target of $249.51. Although the broker concedes that CSL's guidance downgrade was disappointing and it remains unclear when US influenza vaccination rates will stabilise, it thinks the share price selldown has been severely overdone. As a result, Morgans believes that its shares are trading on unjustifiably low earnings multiples at present and is recommending investors buy the dip. The CSL share price was fetching $178.50 at Friday's close.

Zip Co Ltd (ASX: ZIP)

Another note out of Macquarie reveals that its analysts have initiated coverage on this buy now pay later provider's shares with a $4.85 price target. According to the note, the broker believes that Zip is an attractive investment option for Aussie investors thanks partly to its US segment. It highlights that this side of the business is currently outpacing peers. And despite US total transaction value (TTV) growing >40% annually, it still has a significant opportunity to acquire new customers in an underserved market. In light of this, it is forecasting Zip to continue to deliver rapid growth in the coming years. This will be supported by increased product adoption, expansion of merchant network, increased customer engagement, and digital product innovation. The Zip share price ended the week at $3.87.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three happy office workers cheer as they read about good financial news on a laptop.
Broker Notes

Macquarie tips more than 20% upside for this ASX mining stock

Let's see why the broker is bullish on this stock.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: APA Group, Macquarie, and Rio Tinto shares

Are these shares buys, holds, or sells? Let's find out.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Macquarie names 2 ASX All Ords stocks set to benefit and 1 likely to suffer following their upcoming AGMs

Macquarie expects very different market reactions following the upcoming AGMs for these ASX All Ords stocks.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A woman scratches her head in dismay as she looks at chaotic scene at a data centre
Broker Notes

Macquarie tips almost 90% upside for Xero shares

Xero is executing well on its strategy and should deliver exceptional returns, Macquarie says.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Should you buy Domino's, Orica, and Xero shares?

Morgans has given its verdict on these popular stocks.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices.
Broker Notes

Leading broker names 1 ASX 200 share to buy and 1 to hold

Here's what the broker is saying about these shares.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »